ATE336241T1 - L-valine für lebererkrankungen - Google Patents
L-valine für lebererkrankungenInfo
- Publication number
- ATE336241T1 ATE336241T1 AT98945536T AT98945536T ATE336241T1 AT E336241 T1 ATE336241 T1 AT E336241T1 AT 98945536 T AT98945536 T AT 98945536T AT 98945536 T AT98945536 T AT 98945536T AT E336241 T1 ATE336241 T1 AT E336241T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatic
- valine
- caused
- active ingredient
- compositions
- Prior art date
Links
- 208000019423 liver disease Diseases 0.000 title abstract 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010000087 Abdominal pain upper Diseases 0.000 abstract 1
- 206010003445 Ascites Diseases 0.000 abstract 1
- 208000002151 Pleural effusion Diseases 0.000 abstract 1
- 206010037660 Pyrexia Diseases 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000005856 abnormality Effects 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000004596 appetite loss Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 208000007386 hepatic encephalopathy Diseases 0.000 abstract 1
- 235000021266 loss of appetite Nutrition 0.000 abstract 1
- 208000019017 loss of appetite Diseases 0.000 abstract 1
- 238000001050 pharmacotherapy Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
- 230000008673 vomiting Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26579397 | 1997-09-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE336241T1 true ATE336241T1 (de) | 2006-09-15 |
Family
ID=17422126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT98945536T ATE336241T1 (de) | 1997-09-30 | 1998-09-30 | L-valine für lebererkrankungen |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP1025844B1 (de) |
KR (2) | KR100562739B1 (de) |
CN (1) | CN1149988C (de) |
AT (1) | ATE336241T1 (de) |
AU (1) | AU9280298A (de) |
CA (1) | CA2305206A1 (de) |
DE (1) | DE69835609T2 (de) |
HK (1) | HK1033275A1 (de) |
TW (1) | TW473387B (de) |
WO (1) | WO1999016433A1 (de) |
ZA (1) | ZA988924B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013912A1 (fr) | 1999-08-23 | 2001-03-01 | Chugai Seiyaku Kabushiki Kaisha | Medicaments destines a la regeneration d'un foie transplante |
AU2001294245B2 (en) | 2000-10-13 | 2006-09-21 | Chugai Seiyaku Kabushiki Kaisha | Compositions for improving lipid metabolism |
WO2003063853A1 (fr) * | 2002-01-31 | 2003-08-07 | Chugai Seiyaku Kabushiki Kaisha | Compositions de reduction de la graisse mesenterique |
TW201113023A (en) * | 2009-06-24 | 2011-04-16 | Ajinomoto Kk | Enhancer of activity of nucleic acid analogue |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
WO2019036471A1 (en) | 2017-08-14 | 2019-02-21 | Axcella Health Inc. | AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE |
AR115585A1 (es) | 2018-06-20 | 2021-02-03 | Axcella Health Inc | Composiciones y métodos para el tratamiento de la infiltración de grasa en músculo |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5668374A (en) * | 1979-11-08 | 1981-06-09 | Jun Sawada | Food composition for hepatic insufficiency |
JPS61186320A (ja) * | 1985-02-12 | 1986-08-20 | Morishita Seiyaku Kk | アミノ酸製剤 |
JP2618653B2 (ja) * | 1987-09-22 | 1997-06-11 | ルセル森下株式会社 | 肝性脳症患者用アミノ酸製剤 |
EP0605742A4 (en) * | 1992-06-26 | 1996-01-03 | Nonna Dmitrievna Kislyakova | Agent with adaptogenic activity. |
ES2238680T3 (es) * | 1994-06-23 | 2005-09-01 | Chugai Seiyaku Kabushiki Kaisha | Utilizacion de valina para la preparacion de un medicamento para la regeneracion del higado. |
-
1998
- 1998-09-24 TW TW087115898A patent/TW473387B/zh not_active IP Right Cessation
- 1998-09-30 ZA ZA988924A patent/ZA988924B/xx unknown
- 1998-09-30 AU AU92802/98A patent/AU9280298A/en not_active Abandoned
- 1998-09-30 KR KR1020057002626A patent/KR100562739B1/ko not_active IP Right Cessation
- 1998-09-30 WO PCT/JP1998/004405 patent/WO1999016433A1/ja active IP Right Grant
- 1998-09-30 AT AT98945536T patent/ATE336241T1/de not_active IP Right Cessation
- 1998-09-30 EP EP98945536A patent/EP1025844B1/de not_active Expired - Lifetime
- 1998-09-30 CA CA002305206A patent/CA2305206A1/en not_active Abandoned
- 1998-09-30 DE DE69835609T patent/DE69835609T2/de not_active Expired - Fee Related
- 1998-09-30 EP EP06016819A patent/EP1714649A3/de not_active Withdrawn
- 1998-09-30 KR KR1020007003441A patent/KR20010030820A/ko active Search and Examination
- 1998-09-30 CN CNB988107287A patent/CN1149988C/zh not_active Expired - Fee Related
-
2001
- 2001-06-11 HK HK01103997A patent/HK1033275A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1025844A4 (de) | 2002-10-02 |
DE69835609T2 (de) | 2007-08-09 |
KR20010030820A (ko) | 2001-04-16 |
DE69835609D1 (de) | 2006-09-28 |
EP1714649A2 (de) | 2006-10-25 |
KR100562739B1 (ko) | 2006-03-20 |
EP1025844A1 (de) | 2000-08-09 |
AU9280298A (en) | 1999-04-23 |
EP1714649A3 (de) | 2007-09-05 |
EP1025844B1 (de) | 2006-08-16 |
ZA988924B (en) | 1999-03-30 |
WO1999016433A1 (fr) | 1999-04-08 |
CN1149988C (zh) | 2004-05-19 |
CN1278168A (zh) | 2000-12-27 |
TW473387B (en) | 2002-01-21 |
HK1033275A1 (en) | 2001-08-24 |
CA2305206A1 (en) | 1999-04-08 |
KR20050054921A (ko) | 2005-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0515033A8 (pt) | processo para a obtenção de uma mistura de polipetídeos de trifluoroacetila, mistura de polipeptídeos de trifluoroacetila, e, processos para a obtenção de uma composição farmacêutica, e para a produção de acetato de glatirâmetro | |
EP0784469A4 (de) | Mittel zur verabreichung von antigenen | |
NO992463D0 (no) | N-(aryl/heteroarylacetyl)aminosyreestere, farmas°ytiske sammensetninger som omfatter det samme, og metoder for inhibering av <beta>-amyloidpeptidfrigivelse og/eller dens syntese ved bruk av slike forbindelser | |
ATE296545T1 (de) | Zusatz für die wiederherstellung des wachstumhormonspiegels | |
DE69723812D1 (de) | Aminosäurezusammensetzungen | |
DK0421309T4 (da) | Proteinhydrolysater | |
CA2530927A1 (en) | Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases | |
NO178665C (no) | Fosfopeptider og sammensetning for kosmetiske formål | |
RAPLEY et al. | Tissue distributions, substrate specificities and molecular sizes of human peptidases determined by separate gene loci | |
FI844364L (fi) | Produkt, som kan foeraendras. | |
DE69835609D1 (de) | L-valine für lebererkrankungen | |
WO1995003327A3 (en) | Peptides for neutralizing the toxicity of lipid a | |
CA2269107A1 (en) | Clamping member for at least one support pin for belt conveyor components | |
HAGIHIRA et al. | INTESTINAL ABSORPTION OF AMINO ACIDS III. INTERFERENCE BETWEEN AMINO ACIDS DURING INTESTINAL ABSORPTION | |
DK0948328T3 (da) | Sammensætninger baseret på aminosyrer | |
ES487926A0 (es) | Procedimiento de fabricacion de compuestos que resultan de la fijacion de muramilpeptidos, sus homologos y derivados | |
DK0656178T3 (da) | Nærende sammensætninger til kontrol af nitrogenmetabolismen | |
DK0548177T3 (da) | 5-Aminosalicylsyrederivater til terapi af kroniske inflammatoriske tarmsygdomme | |
DE60136573D1 (de) | Gewebefixativzusammensetzung | |
WO1997039122A3 (en) | Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof | |
WO2002036166A8 (en) | Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease | |
DE50010583D1 (de) | Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel | |
RU96114536A (ru) | Ингибиторы прорастания семян | |
ES1034253U (es) | Grapa de fijacion perfeccionada, aplicable en hebillas, adornos y similares. | |
SI1527197T1 (sl) | Povezava EDG5 polimorfizma V286A z diabetes mellitusom tipa II in vensko trombozo/pljučno embolijoin uporaba le-te |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |